ArticleBritish journal of pharmacology2012

A novel µ-conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors.

Philippe Favreau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.